The arrangement is part if the Global Stem Cell Group's global expansion program.
MIAMI (PRWEB) October 24, 2014
Global Stem Cells Group, Inc. has signed BIOMEN S.A and its founder, anti-aging and regenerative medicine specialist Dra. Mariella Tanzi, to represent the Miami-based stem cell company as an exclusive representative for the Costa Rican territory. Tanzi will also open a new Regenestem clinic in the Costa Rican capital of San Jose.
The arrangement is part of the Global Stem Cells Group’s global expansion program, which requires affiliate representatives to have more than five years experience in the health care industry with at least some experience in regenerative medicine.
Tanzi will be instrumental in helping to manage the company’s growth in Costa Rica. Her responsibilities will include arranging a number of stem cell training courses at the Regenestem facility in Costa Rica over a one-year period, certification of physicians, and willingness to organize an annual stem cell and regenerative medicine symposium in their territory.
“Our main focus is to organize Costa Rica’s first annual symposium on stem cells and regenerative medicine in 2015,” says Global Stem Cells Group Founder Benito Novas. “This new alliance will allow us to establish Regenestem as a leader in regenerative medicine therapies in Costa Rica.”
To learn more about the Global Stem Cells Group alliance program, visit the website at http://www.stemcellsgroup.com, email bnovas(at)stemcellsgroup(dot)com, or call 305.224.1858.
About Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.